BridgeBio Pharma Inc (BBIO)
23.24
+0.20
(+0.87%)
USD |
NASDAQ |
Nov 21, 16:00
23.26
+0.02
(+0.11%)
After-Hours: 20:00
BridgeBio Pharma Market Cap: 4.392B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 4.392B |
| November 20, 2024 | 4.354B |
| November 19, 2024 | 4.260B |
| November 18, 2024 | 4.224B |
| November 15, 2024 | 4.483B |
| November 14, 2024 | 4.557B |
| November 13, 2024 | 4.685B |
| November 12, 2024 | 4.653B |
| November 11, 2024 | 4.936B |
| November 08, 2024 | 5.120B |
| November 07, 2024 | 4.891B |
| November 06, 2024 | 4.840B |
| November 05, 2024 | 4.823B |
| November 04, 2024 | 4.762B |
| November 01, 2024 | 4.815B |
| October 31, 2024 | 4.424B |
| October 30, 2024 | 4.496B |
| October 29, 2024 | 4.630B |
| October 28, 2024 | 4.619B |
| October 25, 2024 | 4.505B |
| October 24, 2024 | 4.568B |
| October 23, 2024 | 4.621B |
| October 22, 2024 | 4.713B |
| October 21, 2024 | 4.755B |
| October 18, 2024 | 4.917B |
| Date | Value |
|---|---|
| October 17, 2024 | 4.950B |
| October 16, 2024 | 4.978B |
| October 15, 2024 | 4.796B |
| October 14, 2024 | 4.872B |
| October 11, 2024 | 4.895B |
| October 10, 2024 | 4.717B |
| October 09, 2024 | 4.419B |
| October 08, 2024 | 4.674B |
| October 07, 2024 | 4.694B |
| October 04, 2024 | 4.768B |
| October 03, 2024 | 4.844B |
| October 02, 2024 | 4.740B |
| October 01, 2024 | 4.687B |
| September 30, 2024 | 4.812B |
| September 27, 2024 | 4.690B |
| September 26, 2024 | 4.603B |
| September 25, 2024 | 4.609B |
| September 24, 2024 | 4.674B |
| September 23, 2024 | 4.776B |
| September 20, 2024 | 5.028B |
| September 19, 2024 | 5.045B |
| September 18, 2024 | 4.881B |
| September 17, 2024 | 5.026B |
| September 16, 2024 | 4.925B |
| September 13, 2024 | 4.923B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
769.49M
Minimum
May 11 2022
10.77B
Maximum
Feb 08 2021
4.492B
Average
4.541B
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals Inc | 31.83B |
| Pfizer Inc | 142.41B |
| Vertex Pharmaceuticals Inc | 115.98B |
| PTC Therapeutics Inc | 3.308B |
| Bristol-Myers Squibb Co | 118.10B |
Market Cap Related Metrics
| PS Ratio | 19.46 |
| Price | 23.24 |
| Earnings Yield | -10.37% |